Georgios Koliakos

Biohellenika S.A was founded at 2006 and is an internationally recognized cord blood processing and storage facility with its main offices and laboratories in Thessaloniki and offices in Athens Greece. Currently it stores more than 30,000 umbilical cord blood units, 20,000 units of Wharton Jelly stem cells, and over 2,500 dental stem cell units.  It is accredited by AABB and operates in 7 countries as Greece, Italy, Serbia, Bulgaria, North Macedonia, Cyprus and Philippines and has successfully provided cord blood stem cell grafts for autologous transplantation as well as is actively involved in stem cell therapies and successfully releases for autologous therapies. Biohellenika S.A owns 5 patents and is ready to fill more than 5 new patents. Biohellenika owns a diagnostic molecular biology and biochemistry laboratory, performing prenatal diagnosis, paternity tests, PCR tests and other specialized tests focusing in gynecological and fertility tests, cancer diagnostic and follow up and biological aging assessment. The R&D department of Biohellenika S.A is in collaboration with distinguished Academic Professors and research centers and is preparing new services and applications in the field of Stem Cells, Genomics and Molecular Analysis, Regenerative Medicine and Tissue Engineering and participates in national and international grants. The R&D department has developed know how, for services such as mesenchymal stem cells from the whole length of the umbilical cord (patented and used), stem cell extraction from placenta (patented and used), VSEL stem cells collection and storage  from umbilical cord blood (used), mesenchymal stem cell collection from deciduous teeth (used), collection and storage of mesenchymal stem cells from the adipose tissue (used), collection of stem cells from menstrual blood, immune cell collection and storage (such as dendritic cells, monocytes, NK cells and T lymphocytes), Amniotic membrane collection and preparation for ophthalmology use, fibroblast culture for aesthetic use and wound healing, cartilage cells culture for orthopedic use, expansion of haematopetic stem cells, skin culture for use in burns, IPS cell production, and products such as an anti aging liposome based crème with PRP (used), a special PRP Fibrin that can also contain IL1 shed receptor (used), and a CHO based cell line producing Interferon beta. The know how of the R&D department allows the production of cat T cells and any transgenic cell line. The R&D department of Biohellenika S.A has published more than 50 scientific papers, received several awards, and has successfully completed 9 national collaborative research Grants.